Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.

Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. According to the Global Year Against Neuropathic Pain 2014-2015 report by International Association of the Study of Pain, around 7%8% of adults suffer from chronic pain with neuropathic characteristics. Furthermore, Pfizers patent expiry of Lyrica (Pregabalin) in 2018 is anticipated to increase the market share of generic manufacturing companies in the UK.


Download Sample @ www.alliedmarketresearch.com/request-toc-and-sample/2652

However, stringent government regulations, lack of awareness about neuropathic pain, presence of substitutes of Pregabalin such as gabapentin, and adverse drug effects hinder the market growth. High investment in developing nations are proving new opportunities for the market players.

The Pregabalin market is segmented on the basis of application, end user, and geography. Based on application, the market is divided into epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Based on the end user, it is classified into research institutes, pharmaceutical companies, and others (hospitals and clinics). Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits
• The study provides an in-depth analysis of the global Pregabalin market, with current trends and future estimations to elucidate the investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
• The report presents a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of different segments facilitates to understand various products of the market.
• Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

List of players profiled in the report

• Pfizer Inc.
• Torrent Pharmaceuticals Ltd.
• Lupin Limited
• Zydus Cadila Healthcare Ltd.
• Cipla Limited
• Genesis Remedies
• Sanofi
• Medley Pharmaceuticals Limited
• Genesis Biotec Inc.
• Biomax

Send Enquiry @ www.alliedmarketresearch.com/purchase-enquiry/2652

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.